• About Us
    • Contact Us
    • Login
    • ObGFirst
  • COVID-19
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • #GrandRounds
  • My Bookshelf
  • Now@ObG
  • Media
About Us Contact Us Login ObGFirst
  • COVID-19
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • 0 CME Hours
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • #GrandRounds
  • My Bookshelf
  • Now@ObG
  • Media
COVID-19 Clinical Outcomes

Are COVID-19 Mortality Rates in the US Improving Over Time?

image_pdfFavoriteLoadingFavorite

BACKGROUND AND PURPOSE:

  • Asch et al. (JAMA Internal Medicine, 2020) examined the change in COVID-19 hospital mortality rates over the first 6 months of the pandemic

METHODS:

  • Cohort study (January 1, 2020 to June 30, 2020)
  • Participants
    • Adults admitted to a US hospital with COVID-19
  • Exposures
    • Hospital characteristics
      • Size | Number of ICU beds | Academic and profit status | Hospital setting and regional characteristics | COVID-19 case burden
  • Primary outcome
    • Hospital’s risk-standardized event rate (RSER) of 30-day in-hospital mortality or referral to hospice, with adjustment for patient-level characteristics
    • The authors examined whether hospital characteristics were associated with RSERs or their change over time
    • Subset analysis of patients admitted to hospitals that treated ≥10 COVID-19 patients

RESULTS:

  • 38,517 adults | 955 hospitals
    • Mean (SD) age 70.2 (15.5) years | 51.0% women
  • Mean (SD) hospital-level RSER: 11.8% (2.5%)
    • Mean RSER in the worst-performing quintile of hospitals: 15.65%
    • Mean RSER in the best-performing quintile of hospitals: 9.06%
    • Absolute difference 6.59 percentage points (95% CI, 6.38% to 6.80%); P < 0.001
  • Mean RSERs improved in all but 1 of the 398 hospitals that treated ≥10 COVID-19 patients
    • 94% (376 hospitals) improved by at least 25%
    • The overall mean (SD) RSER declined from 16.6% (4.0%) to 9.3% (2.1%)
    • Absolute differences in rates of mortality or referral to hospice between the worst- and best-performing quintiles of hospitals decreased over time
      • January 1 to April 30: 10.54 percentage points (95% CI, 10.03% to 11.05%); P < 0.001
      • May 1 to June 30: 5.59 percentage points (95% CI, 5.33% to 5.86%); P <0 .001
  • Higher county-level COVID-19 case rates were associated with worse RSERs
    • Case rate declines were associated with improvement in RSERs

CONCLUSION:

  • Hospital mortality rates due to COVID-19 declined “sharply” during the first six months of the pandemic
    • 94% of hospitals had a relative mortality reduction of >25%
    • Accrued clinical experience and use of medications (e.g., dexamethasone) could account for some of this improvement
  • Mortality rate declines were associated with decreased COVID-19 case loads at the county level
  • The authors state

This study revealed that outcomes for patients with COVID-19 rely not only on individual-level risk factors, but also on the hospital where care is received

The association between high community COVID-19 case loads and both worse RSERs and greater improvement in RSERs suggests hospitals do worse when they are burdened with cases and is consistent with imperatives to flatten the curve

Learn More – Primary Sources:

Variation in US Hospital Mortality Rates for Patients Admitted With COVID-19 During the First 6 Months of the Pandemic

Get COVID-19 Research Summaries Direct to Your Phone, with ObGFirst

ObGFirst® – Try It Free! »

image_pdfFavoriteLoadingFavorite
< Previous
All COVID-19 Clinical Outcomes Posts
Next >

Related ObG Topics:

Characteristics and Outcomes for 5700 COVID-19 Patients Hospitalized in the New York City Area
CDC Weekly Update: Which Comorbidities are Associated with COVID-19 in the US?
COVID-19 Patients and ICU Outcomes in Italy: Respiratory Findings and Mortality

Sections

  • COVID-19
  • Alerts
  • OB
  • GYN
    • GYN
    • Sexual Health
  • 2T US Atlas
  • The Genome
  • Primary Care
  • Your Practice
  • #Grand Rounds
  • My Bookshelf
  • Now@ObG
  • Media

ObG Library

  • Hysteroscopy
  • Fertility
  • Site Map/
  • © ObG Project/
  • Terms and Conditions/
  • Privacy/
  • Contact Us/
© ObG Project
SSL Certificate


  • Already an ObGFirst Member?
    Welcome back

    Log In

    Want to sign up?
    Get guideline notifications
    CME Included

    Sign Up

Get Guideline Alerts Direct to Your Phone
Try ObGFirst Free!

Sign In

Lost your password?

Sign Up for ObGFirst and Stay Ahead

  • - Professional guideline notifications
  • - Daily summary of a clinically relevant
    research paper
  • - Includes 1 hour of CME every month

ObGFirst Free Trial

Already a Member of ObGFirst®?

Please log in to ObGFirst to access the 2T US Atlas

Password Trouble?

Not an ObGFirst® Member Yet?

  • - Access 2T US Atlas
  • - Guideline notifications
  • - Daily research paper summaries
  • - And lots more!
ObGFirst Free Trial

Media - Internet

Computer System Requirements

OBG Project CME requires a modern web browser (Internet Explorer 10+, Mozilla Firefox, Apple Safari, Google Chrome, Microsoft Edge). Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Apple QuickTime, Adobe Acrobat, Microsoft PowerPoint, Windows Media Player, or Real Networks Real One Player.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information
presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Jointly provided by

NOT ENOUGH CME HOURS

It appears you don't have enough CME Hours to take this Post-Test. Feel free to buy additional CME hours or upgrade your current CME subscription plan

Subscribe

JOIN OBGFIRST AND GET CME/CE CREDITS

One of the benefits of an ObGFirst subscription is the ability to earn CME/CE credits from the ObG entries you read. Tap the button to learn more about ObGFirst

Learn More
Leaving ObG Website

You are now leaving the ObG website and on your way to PRIORITY at UCSF, an independent website. Therefore, we are not responsible for the content or availability of this site